All Stories

  1. Design, synthesis, biological evaluation and docking studies of new 3-(4,5-dihydro-1 H -pyrazol/isoxazol-5-yl)-2-phenyl-1 H -indole derivatives as potent antioxidants and 15-lipoxygenase inhibitors

    Article • European Journal of Medicinal Chemistry, February 2018, Elsevier

    Mostafa El-Miligy, Dr. Shaymaa Emam Kassab

  2. Dual inhibitors of hepatitis C virus and hepatocellular carcinoma: design, synthesis and docking studies

    Article • Future Science OA, January 2018, Future Science

    Mostafa El-Miligy

  3. Synthesis of thymol derivatives as potential non-irritant antimicrobial and insecticidal agents

    Article • Current Bioactive Compounds, November 2017, Bentham Science Publishers

    Mostafa El-Miligy

  4. Synthesis of piperazine-based thiazolidinones as VEGFR2 tyrosine kinase inhibitors inducing apoptosis

    Article • Future Medicinal Chemistry, October 2017, Future Science

    Mostafa El-Miligy

  5. New hybrid molecules combining benzothiophene or benzofuran with rhodanine as dual COX-1/2 and 5-LOX inhibitors: Synthesis, biological evaluation and docking study

    Article • Bioorganic Chemistry, June 2017, Elsevier

    Mostafa El-Miligy

  6. New benzothiophene derivatives as dual COX-1/2 and 5-LOX inhibitors: synthesis, biological evaluation and docking study

    Article • Future Medicinal Chemistry, April 2017, Future Science

    Mostafa El-Miligy

  7. New heterocyclic hybrids of pyrazole and its bioisosteres: Design, synthesis and biological evaluation as dual acting antimalarial-antileishmanial agents

    Article • European Journal of Medicinal Chemistry, April 2015, Elsevier

    Mostafa El-Miligy

  8. Synthesis of novel benzofuran and related benzimidazole derivatives for evaluation ofin vitro anti-HIV-1, anticancer and antimicrobial activities

    Article • Archives of Pharmacal Research, October 2006, Springer Science + Business Media

    Mostafa El-Miligy

  9. Synthesis andin vitro evaluation of some novel benzofuran derivatives as potential anti-HIV-1, anticancer, and antimicrobial agents

    Article • Archives of Pharmacal Research, January 2006, Springer Science + Business Media

    Mostafa El-Miligy